A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Clinical trial NCT00455052 · COMPLETED

Trial details

NCT number: NCT00455052
Sponsor: Mersana Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Non-small Cell Lung Cancer

Start date: 2011-03-01
Primary completion: 2011-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.